冠動脈バイパス移植を受けた患者の術後の心房細動におけるビタミンD補給: 系統的レビューとメタ解析

Taimoor Ashraf¹, Muhammad Abdul Moiz², Ganesh Kumar³

¹Department of Medicine, Nishtar Medical University, Multan, Pakistan.

Annals of medicine and surgery (2012)

|August 25, 2025

まとめ

ビタミンDサプリメントは,冠動脈バイパス移植 (CABG) を受けている患者で,術後の心房細動 (POAF) のリスクを大幅に軽減します. この研究では,入院期間に大きな影響はなかった.

科学分野:

心血管医学
内分泌学
栄養学

背景:

術後の心房細動 (POAF) は,冠動脈バイパス移植 (CABG) の後の一般的な合併症である.
ビタミンD欠乏症は心臓手術患者の多くで,有害な結果と関連している可能性があります.
ビタミンDサプリメントがPOAFを軽減する役割は,まだ調査中です.

研究の目的:

CABG手術後のPOAFの予防におけるビタミンDサプリメントの有効性を評価する.
CABG患者の入院期間に対するビタミンDの影響を評価する.

主な方法:

ランダム化制御試験 (RCT) の体系的レビューとメタ解析が行われました.
2023年5月まで,PubMedとコクラン・セントラル・レジスター・オブ・コントロールド・トライアルの検索が行われました.
694人の患者が参加した4つのRCTは,POAFの発生率と入院を分析するために含まれていた.

主要な成果:

ビタミンDサプリメントは,CABG患者におけるPOAFの発生率を著しく低下させた (RR:0. 55;95%CI:0. 40から0. 76;P =0. 0003).
POAFの発生率に対する観察された効果は,非常に低い異質性 (I2 = 1%) であった.
ビタミンDサプリメントは,入院期間を有意に短縮しなかった (WMD: - 0. 14;95%CI: - 0. 82から0. 53;P = 0. 68;I2 = 34%).

結論:

ビタミンDサプリメントは,CABGを受ける患者におけるPOAFの発生率を低減するのに有効です.
多様な集団を対象としたさらなる大規模な研究と,より広範な結果測定が必要である.
CABG患者の補助療法としてビタミンDの補給を検討することを支持しています.

キーワード:

心拍の乱れ冠動脈バイパス移植術後の心房細動ビタミンD

さらに関連する動画

23:33

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation

Published on: February 28, 2012

83.8K

08:42

Cox-Maze IV Procedure Concomitant with Valvular Surgery In Situs Inversus Dextrocardia: A Single-Center Experience in China

Published on: February 11, 2022

3.6K

関連する概念動画

01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...

01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

1.3K

Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...

1.3K

01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...

01:23

Peripheral Artery Disease V: Postoperative Nursing Management

During the postoperative period, it is crucial to focus on maintaining circulation, identifying and managing potential complications, and planning for discharge.Nursing AssessmentVital signs monitoring: Regularly monitor vital signs, including blood pressure, heart rate, respiratory rate, and temperature, to detect early signs of complications such as bleeding and infection.Circulation assessment: Monitor pulses, perform Doppler assessments, and check capillary refill, color, temperature, and...

01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.

01:20

Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers

987

Class IV antiarrhythmic drugs, such as verapamil and diltiazem, block calcium channels. They primarily affect the heart, slowing the conduction in calcium-dependent tissues like the SA and AV nodes. These drugs manage reentrant supraventricular tachycardia (SVT) and reduce ventricular rate in atrial flutter/fibrillation.
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...

987

関連する実験動画